Hussein A. Tawbi

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Vancheswaran Gopalakrishnan, Luigi Nezi, Alexandre Reuben et al. · Science · 2017 · 4.7K citations · Full text

Life Sciences, Immunology, Oncology +17

B cells are associated with survival and immunotherapy response in sarcoma

Florent Petitprez, Aurélien de Reyniès, Emily Z. Keung et al. · Nature · 2020 · 1.9K citations · Full text

Medicine, Immunology, Oncology +17

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack et al. · The Lancet Oncology · 2017 · 1.4K citations · Full text

Medicine, Oncology, Pharmacology +13

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

Hussein A. Tawbi, Peter Forsyth, Alain P. Algazi et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

Medicine, Neurology, Oncology +14

Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance

Whijae Roh, Alexandre Reuben, Christine N. Spencer et al. · Science Translational Medicine · 2017 · 920 citations · Full text

Medicine, Immunology, Oncology +17